According to the US Department of Justice (DOJ), Patients Choice Laboratories (PCL), an Indianapolis-based diagnostic laboratory company, has agreed to pay $9.6m to resolve allegations that it violated the False Claims Act (FCA) and the Anti-Kickback Statute (AKS).
DOJ said PCL did so by knowingly filing claims to
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
